Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro
- 31 August 1986
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 23 (2-3) , 229-238
- https://doi.org/10.1016/0262-1746(86)90190-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Selective inhibition of the cyclooxygenase pathway of the arachidonic acid cascade by the nonsteroidal antiinflammatory drug isoxicamDrug Development Research, 1985
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Differential effects of anti-inflammatory drugs on lipoxygenase and cyclo-oxygenase activities of neutrophils from a reverse passive Arthus reactionBiochemical and Biophysical Research Communications, 1983
- Selective inhibition of the lipoxygenase metabolic pathway of arachidonic acid by the SRS-A antagonist, FPL 55712Prostaglandins, 1983
- Prostaglandin endoperoxide metabolism by microsomes of whole kidneys from normal, congenital unilateral hydronephrotic and unilateral ureteral obstructed ratsProstaglandins, 1982
- Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, and Other Derivatives of Carbon‐20 Unsaturated Fatty AcidsJournal of Neurochemistry, 1982
- Inhibition of the release of slow-reacting substance of anaphylaxis by inhibitors of lipoxygenase activityJournal of Pharmacy and Pharmacology, 1980
- ANTAGONISM BY FENAMATES OF PROSTAGLANDIN ACTION IN GUINEA‐PIG AND HUMAN ALIMENTARY MUSCLEBritish Journal of Pharmacology, 1980
- Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.British Journal of Clinical Pharmacology, 1979
- A new approach to anti-inflammatory drugsBiochemical Pharmacology, 1979